Biotechnology CEO Calls on President Joe Biden to Implement Next-Gen Diagnostic Technologies in Global Battle against COVID-19 Variants

/PRNewswire/ -- At a time when the U.S. Food and Drug Administration ("FDA") is considering Emergency Use Authorization submissions for SARS-CoV-2 variant...

Related Keywords

Germany ,Arizona ,United States ,Australia ,Milan ,Lombardia ,Italy ,Denmark ,United Kingdom ,Israel ,Washington ,White House ,District Of Columbia ,Belgium ,South Africa ,Canada ,Britain ,South African ,American ,Chuck Schumer ,Mitchell Mcconnell ,Kevin Mccarthy ,Nancy Pelosi ,Joe Biden ,Kyrsten Sinema ,Ellen Mellody ,States Joe Biden ,National Institute Of Health ,National Institutes Of Health ,Drug Administration ,Emergency Use Authorization ,National Institute ,Honorable President ,United States Joe ,President Biden ,Thenew York Timespublished ,Omicron Cases ,Next Generation ,Pathogendx ,